-
Clinical Briefs: Risk for Zoster from the Vaccine in Immunosuppressed Persons, Elucidating the Best, Cerebral Aneurysms: Whats in Your
Patients Future?
-
Off-label prescribing is common in primary care and most of the time lacks the scientific evidence to support it.
-
The ECG was obtained from a patient whose blood pressure was dropping. How many reasons can you cite to support a diagnosis of ventricular tachycardia (VT)?
-
THE FDA HAS APPROVED A SECOND WEIGHT-LOSS DRUG WITHIN the last month. This product is a combination of phentermine, an anorectic, and the antiepileptic topiramate. Phentermine/topiramate (PHEN/TPM) is manufactured by Catalent Pharma Solutions and marketed by Vivus Inc. as Qsymia.
-
-
The FDA has approved a new pancreatic enzyme preparation for the treatment of pancreatic insufficiency. Pancrelipase contains porcine derived lipases, proteases, and amylases. It is marketed by Aptalis Pharma U.S. Inc. as Viokace.
-
-
The authors concluded that ECG LVH and LVH with strain were independently predictive of cardiovascular events, including aortic valve replacement in asymptomatic patients with moderate aortic stenosis.
-
In a double-blind, randomized clinical trial, amoxicillin therapy did not improve outcomes in patients with clinically diagnosed acute rhinosinusitis.
-
In a cross-sectional sample of postmenopausal women not using hormonal therapy, higher serum levels of estrogen were associated with improved semantic memory and verbal episodic memory abilities.
